Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis Review uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Hepatitis B, Chronic
  • Pregnancy Complications, Infectious

abstract

  • Antiviral therapy improves HBV suppression and reduces MTCT in women with chronic HBV infection with high viral load compared to the use of hepatitis B immunoglobulin and vaccination alone; the use of telbivudine, lamivudine, and tenofovir appears to be safe in pregnancy with no increased adverse maternal or fetal outcome. (Hepatology 2016;63:319-333).

publication date

  • January 2016

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/hep.28302

PubMed ID

  • 26565396

Additional Document Info

start page

  • 319

end page

  • 33

volume

  • 63

number

  • 1